Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimizing Malaria Treatment for HIV-Malaria Co-Infected Individuals by Addressing Drug Interactions Between Artemether-Lumefantrine and Efavirenz; a Randomized Controlled Trial

NCT04708496 is registered in ClinicalTrials.gov with Makerere University as lead sponsor.

NCT NCT04708496
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04708496 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimizing Malaria Treatment for HIV-Malaria Co-Infected Individuals by Addressing Drug Interactions Between Artemether-Lumefantrine and Efavirenz; a Randomized Controlled Trial
Lead sponsor
Makerere University
Phase
Phase 4
Overall status
Unknown status
Start date
January 18, 2021
Completion date
March 31, 2024
Enrollment
888 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hiv coinfection, malaria